Originally cloned in 1993 (2) as a cytokine derived from activated T cells, IL-17A is now recognized as a key pro-inflammatory cytokine in chronic immune-mediated inflammatory diseases, particularly psoriasis, and spondyloarthritis (3). The gene discussed is IL17A; the disease is spondyloarthropathy.